Results 21 to 30 of about 4,949,325 (279)

Basal Ganglia and Thalamic Infarction

Pediatric Neurology Briefs, 1997
The signs, symptoms, and radiographic findings in 36 children, newborns to 13 years of age, with ischemic infarctions of the basal ganglia, internal capsule, or thalamus are reported from the University of Texas Southwestern Medical Center, Dallas, TX.
J Gordon Millichap
doaj   +1 more source

Did the "Woman in the Attic" in Jane Eyre Have Huntington Disease?

Tremor and Other Hyperkinetic Movements, 2015
Background: References to neurologic disorders are frequently found in fictional literature and may precede description in the medical literature. Aim: Our aim was to compare Charlotte Brontë’s depiction of Bertha Mason in Jane Eyre to the ...
Elizabeth A. Coon, Anhar Hassan
doaj   +1 more source

Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates. [PDF]

PLoS ONE, 2017
Huntington disease is associated with elongation of a CAG repeat in the HTT gene that results in a mutant huntingtin protein. Several studies have implicated N-terminal huntingtin protein fragments in Huntington disease pathogenesis.
Menno H Schut, Stefano Patassini, Eric H Kim, Jocelyn Bullock, Henry J Waldvogel, Richard L M Faull, Barry A Pepers, Johan T den Dunnen, Gert-Jan B van Ommen, Willeke M C van Roon-Mom   +9 more
doaj   +1 more source

Huntington Disease in Asia

Chinese Medical Journal, 2015
Objective: The objective was to review the major differences of Huntington disease (HD) in Asian population from those in the Caucasian population. Data Sources: Data cited in this review were obtained from PubMed database and China National Knowledge ...
Miao Xu, Zhi-Ying Wu
doaj   +1 more source

High Dose Sugammadex Administiration in a Case of Huntington Chorea

Medicine Science, 2016
Huntington Chorea is central nervues system disease that is inherited autosomal dominantly which causes miscellaneous difficulties and has features by the aspect of anesthesia management.
Mehmet Selcuk Uluer, Mehmet Sargin, Eyup Aydogan, Sadik Ozmen   +3 more
doaj   +1 more source

Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study

Frontiers in Neurology, 2021
The momentum of gene therapy in Huntington's disease (HD) deserves biomarkers from easily accessible fluid. We planned a study to verify whether plasma miRNome may provide useful peripheral “reporter(s)” for the management of HD patients. We performed an
Michela Ferraldeschi, Silvia Romano, Simona Giglio, Carmela Romano, Emanuele Morena, Rosella Mechelli, Viviana Annibali, Martina Ubaldi, Maria Chiara Buscarinu, Renato Umeton, Renato Umeton, Renato Umeton, Renato Umeton, Gabriele Sani, Gabriele Sani, Andrea Vecchione, Marco Salvetti, Marco Salvetti, Giovanni Ristori, Giovanni Ristori   +19 more
doaj   +1 more source

How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease [PDF]

, 2015
The retest effect-improvement of performance on second exposure to a task-may impede the detection of cognitive decline in clinical trials for neurodegenerative diseases.
S. Katsahian, Multicentre Intracerebral Grafting in Huntington\u27s Disease Group, P. Krystkowiak, A.C. Bachoud-Levi, F. Supiot, L. Cleret de Langavant, European Huntington\u27s Disease Initiative Study Group, K. Youssov, C. Verny, C. Schramm, J.F. Démonet   +10 more
core   +1 more source

Bilateral Striatal Syndromes

Pediatric Neurology Briefs, 1993
The clinical manifestations and outcome in 13 patients with bilateral basal ganglia lesions and neurological dysfunction are reported from the Child Neurology Unit, Vall D’Hebron University Hospital, Barcelona, Spain.
J Gordon Millichap
doaj   +1 more source

Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. [PDF]

, 2012
Huntington's disease (HD) is a fatal, inherited neurodegenerative disorder caused by an expanded CAG repeat in the gene encoding huntingtin (HTT). Therapeutic approaches to lower mutant HTT (mHTT) levels are expected to proceed to human trials, but ...
Salman Haider, Weiss, A, Rachael I. Scahill, Sarah J. Tabrizi, Ulrike Träger, Bates, G, Stephan Grueninger, Wild, Edward J., Weiss, Andreas, Scahill, R, Ralph Andre, Farmer, Ruth, Macdonald, Douglas, Haider, Salman, Macdonald, D, Scahil, Rachael I., Grueninger, Stephan, Chris Frost, Frost, C, Farmer, R, Wild, E, Bilbe, G, Tabrizi, SJ, Ruth Farmer, Tabrizi, Sarah J., Landles, C, Nayana Lahiri, Gillian P. Bates, Edward J. Wild, Scahill, Rachael I, Douglas Macdonald, Rainer Kuhn, Andre, R, Frost, Chris, Kuhn, R, Grueninger, S, Bates, GP, Wild, Edward J, Wild, EJ, Kuhn, Rainer, Graeme Bilbe, Träger, U, Andreas Weiss, Christian Landles, Lahiri, N, Tabrizi, Sarah J, Scahill, RI, Andre, Ralph, Landles, Christian, Traeger, Ulrike, Lahiri, Nayana, Träger, Ulrike, Bilbe, Graeme, Haider, S, Bates, Gillian P, Bates, Gillian P.   +55 more
core   +1 more source

Experience of experimental simulation of Huntington’s disease

Анналы клинической и экспериментальной неврологии, 2017
Huntingtons disease (HD) is an autosomal dominant neurodegenerativedisease characterized by choreic hyperkinesia, cognitivedecline, behavioral disorders, and progressive neuronaldeath affecting primarily the striatum.
A. V. Stavrovskaya, D. N. Voronkov, N. G. Yamshchikova, A. S. Ol’shanskiy, R. M. Khudoerkov, S. N. Illarioshkin   +5 more
doaj   +1 more source